Your Article Summary
See Latest ArticlesPLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard in The U.S.
Corporate News Releases - The Healthcare Sales & Marketing Network, 12/01/08
PLC Systems Inc. announced that it has received full approval from the U.S. Food and Drug Administration (FDA) for its U.S. pivotal trial to study the effectiveness of the Company's RenalGuard System and associated therapy in the prevention of Contrast-Induced Nephropathy (CIN).
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis receives approval in the European Union for Onbrez Breezhaler, a new once-daily bronchodilator for patients with COPD
Novartis, 12/04/09
Safety concerns slow new drug review and approval processes
Formulary , 12/02/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09